NASDAQ:FIXX
Delisted

Homology Medicines Stock News

etoro logo Buy FIXX
*Your capital is at risk
$0.93
+0 (+0%)
At Close: Jun 24, 2024
In this article we are going to estimate the intrinsic value of Homology Medicines, Inc. (NASDAQ:FIXX) by taking the...
Amia Capital LLP bought a new stake in Homology Medicines Inc (NASDAQ:FIXX) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The
Homology Medicines Inc (NASDAQ:FIXX) has received an average recommendation of “Buy” from the ten research firms that are presently covering the company, Marketbeat Ratings reports. Three equities
Homology Medicines (NASDAQ:FIXX) was upgraded by stock analysts at BidaskClub from a “hold” rating to a “buy” rating in a report issued on Friday, BidAskClub reports. FIXX has been the subject
Homology Medicines (NASDAQ:FIXX) and Leap Therapeutics (NASDAQ:LPTX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the streng
Homology Medicines (FIXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Homology Medicines (FIXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. Active...
Homology Medicines initiated with a Buy at Chardan Chardan FIXX BMRN
Stock analysts at Chardan Capital initiated coverage on shares of Homology Medicines (NASDAQ:FIXX) in a research report issued to clients and investors on Monday, TipRanks reports. The firm set a “b
Chardan Capital analyst Geulah Livshits initiated coverage with a Buy rating on Homology Medicines (FIXX) today and set a price target of $34.00. The
Chardan Capital analyst Geulah Livshits initiated coverage with a Buy rating on Homology Medicines (FIXX – Research Report) today and
BEDFORD, Mass., Feb. 20, 2020 -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today participation and presentations at the following investor.

Three Expensive Biotech Stocks To Avoid

05:50pm, Monday, 17'th Feb 2020
Tesla's stock is often criticized as overpriced. These three biotechs are way more expensive.
3 Stocks That Are Way More Expensive Than Tesla, Stocks: TSLA,ADVM,FIXX,FTSV,IMMU,DNLI,TELL, release date:Feb 17, 2020
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE